[CAS NO. 496955-42-1]  ST 1535

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [496955-42-1]

Fulfillment
Catalog
AS194549
Brand
Arctom Scientific
CAS
496955-42-1

DESCRIPTION [496955-42-1]

Overview

MDLMFCD27987937
Molecular Weight272.31
Molecular FormulaC12H16N8
SMILESCN1C(N2N=CC=N2)=NC3=C1N=C(CCCC)N=C3N

For research use only. We do not sell to patients.

Summary

ST 1535 is a potent and orally active A2A adenosine receptor antagonist. ST 1535 shows antiparkinsonian activity and antitremorigenic effects. ST 1535 has the potential for the research of Parkinson’s disease [1] [2] .


IC50 & Target

A2a adenosine receptor


In Vitro

ST 1535 (0-1000 nM) inhibits forskolin (HY-15371)-induced cAMP formation in CHO cells with IC 50 s of 510, 353, 950, >1000 nM for hA1, hA2A, hA2B, hA3, respectively [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

ST 1535 (0, 5, 10 mg/kg; p.o.) antagonizes catalepsy induced by i.c.v. administration with the A2A adenosine agonist CGS 21680 (HY-13201) [1] .
ST 1535 (10, 20, 40 mg/kg; i.p.) increases the number of contralateral turns induced by l-DOPA (HY-N0304) in rats [2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 5-6 weeks CD1 male mice [1]
Dosage: 0, 5, 10 mg/kg
Administration: P.o.
Result: Antagonized catalepsy induced by i.c.v. administration with the A2A adenosine agonist CGS 21680.
Animal Model: Male Sprague Dawley rats [2]
Dosage: 10, 20, 40 mg/kg
Administration: I.p.
Result: Significantly increased the number of contralateral turns induced by l-DOPA (3 mg/kg i.p.) at 20 and 40 mg/kg.

Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Please store the product under the recommended conditions in the Certificate of Analysis.